Forward Look New Therapies for Metastatic Lung Cancer Several targeted drugs were approved in 2020 to treat the most common type of lung cancer. by Ashley P. Taylor When Cancer’s Spread Is Limited People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment. by Kate Yandell Survivor Profile A Return to Carnival With a renewed sense of purpose, stage IV lung cancer survivor Oswald Peterson returns to his parents’ native Trinidad to celebrate the Caribbean festival. by Lindsey Konkel Immunotherapy Indications Withdrawn In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs? by Anna Goshua Forward Look Scanning Disparities Whether lung cancer patients receive PET scans depends on race, according to a study. by Ashley P. Taylor Forward Look Support Services Help Improve Patient Outcomes Study suggests far-reaching benefits of mental health treatment. by Sharon Tregaskis More Choices to Treat Lung Cancer Advances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer. But having a wider selection of therapies to choose from can make treatments more complex. by Kendall K. Morgan Targeted Therapy for Early-Stage Lung Cancer? A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion. by Ashley P. Taylor Forward Look Cancer Death Rate Decline Makes Headlines Experts say it’s necessary to look behind the statistics. by Delia O’Hara Caregiving With Confidence The Power of Anger Accepting this emotion can be the first step in channeling it for a constructive purpose. by Karen J. Bannan next Cancer Talk A Treatment That Came Just in Time Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma. by Laurie Adami More Data on COVID-19 Vaccination and Cancer Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients. by Anna Goshua Putting the Patient in the Driver’s Seat In her new book, Cancer Support Community executive chair Kim Thiboldeaux offers advice to patients on how to steer their way through a cancer diagnosis, treatment and beyond. by Kevin McLaughlin A Closer Look at Sarcopenia Gastrointestinal oncologist and health services researcher Ryan Nipp discusses new research about how muscle quality correlates with cancer outcomes. by Ashley P. Taylor More Posts